TearSolutions

Charlottesville, VA · Founded 2013 · Privately Held (backing)

Developer of a peptide therapy designed for the treatment of signs and symptoms of dry eye in primary sjögren's syndrome patients. TearSolutions is based in Charlottesville, VA and was founded in 2013. Its last reported valuation was $280 million in Nov 2024. It has raised $44.1 million across 11 recorded rounds; the latest was a $517,000 seed round in Oct 2025.

Last reported valuation
$280.0M
Oct 2026
Priced at
—
Total raised
$44.1M
Last round
Seed Round
Oct 2025

Who backs TearSolutions?

13 investors
InvestorType
Virginia Innovation Partnership CorporationVenture capital
Virginia Venture PartnersVenture capital
CAV AngelsAngel
University of VirginiaOther
Dave Metzak—
Jim Cheng—
LaunchCapital—
Medarva Innovations—
Pharmstandard (Pharmaceuticals)—
Santen Ventures—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

TearSolutions investors

13 investors are on record for TearSolutions, including Virginia Innovation Partnership Corporation, Virginia Venture Partners, CAV Angels and University of Virginia. The seed round in Oct 2025 drew 12 investors.

Free account
More of TearSolutions with a free account
  • ·The complete investor list: 13 names
  • ·Watch TearSolutions: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like TearSolutions. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View